Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2014 09:00 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Report First Quarter 2014 Financial Results After Market on May 6, 2014

BRISBANE, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it will report first quarter 2014 financial results after market close on Tuesday,...
April 24, 2014 03:30 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Broaden Orphan Disease Pipeline With Acquisition of Andromeda Biotech Ltd.

--DiaPep277®, a First-in-Class Immune Intervention Therapy in Phase 3 Testing for New Onset Type 1 Diabetes-- --Hyperion to Host Analyst/Investor Teleconference Today at 8:45 a.m. EDT (5:45...
April 01, 2014 16:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Present at the 13th Annual Needham Healthcare Conference

BRISBANE, Calif., April 1, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the 13th Annual Needham Healthcare Conference on...
March 07, 2014 09:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Present at the 26th Annual Roth Conference

BRISBANE, Calif., March 7, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the 26th Annual Roth Conference on Tuesday, March...
February 27, 2014 16:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics Announces Fourth Quarter and Full Year 2013 Financial Results

BRISBANE, Calif., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today reported net revenue of $18.6 million and $42.2 million for the fourth quarter and full year 2013,...
February 26, 2014 16:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Present at the Cowen and Company 34th Annual Healthcare Conference

BRISBANE, Calif., Feb. 26, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the Cowen and Company 34th Annual Healthcare...
February 25, 2014 09:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics Announces the Publication of Phase 2 Results of Glycerol Phenylbutyrate (GPB) for the Treatment of Hepatic Encephalopathy in Hepatology

BRISBANE, Calif., Feb. 25, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that results of the Phase 2 trial of glycerol phenylbutyrate (GPB) for the treatment of...
February 24, 2014 16:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results After Market on February 27, 2014

BRISBANE, Calif., Feb. 24, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it will report fourth quarter and full year 2013 financial results after market...
February 06, 2014 09:15 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Present at the Leerink Global Healthcare Conference

BRISBANE, Calif., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the Leerink Global Healthcare Conference on Thursday,...
January 08, 2014 16:05 ET | Source: Hyperion Therapeutics, Inc.

Hyperion Therapeutics to Present at the 32nd Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 8, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to present at the 32nd Annual J.P. Morgan Healthcare...